PREECLAMPSIA FOUNDATION
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2000-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.preeclampsia.org/
Clinical Trials
1
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
The Preeclampsia Registry
Recruiting
- Conditions
- PreeclampsiaEclampsiaHELLP SyndromeToxemiaHypertensive Disorder of Pregnancy
- First Posted Date
- 2024-04-22
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- Preeclampsia Foundation
- Target Recruit Count
- 20000
- Registration Number
- NCT06377878
- Locations
- 🇺🇸
Preeclampsia Foundation, Melbourne, Florida, United States
News
Mirvie's RNA Blood Test Predicts Preeclampsia Risk Months Before Symptoms in Major Study
Mirvie's blood test successfully identified 91% of preterm preeclampsia cases in women over 35 without pre-existing conditions, using RNA signatures detectable at 17.5-22 weeks gestation.